Rznomics, Inc

Rznomics Inc. Liver Cancer Drug Candidate Secures Fast Track Designation

Published on 08/07/2025 at 18:08 | prnewswire.co.uk

Rznomics South Korea United Kingdom United States of America

Anticancer drug utilizing Trans-splicing Ribozyme technologySecond Fast Track Designation following brain cancer approvalView original content:https://www.prnewswire.co.uk/news-releases/rznomics-inc-liver-cancer-drug-candidate-secures-fast-track-designation-302378539.html

en | boerse | 67932978 |